Hypertriglyceridemia: lipoprotein receptors and atherosclerosis

Area of Science:

• Lipid metabolism and lipoprotein receptor interactions.
• Cardiovascular disease pathophysiology.
• Atherosclerosis and foam cell formation.

Background:

• Lipoprotein receptors, such as the LDL receptor and beta-VLDL receptor, play critical roles in lipid metabolism.
• Dysregulation of Very Low-Density Lipoprotein (VLDL) catabolism is implicated in hypertriglyceridemia.
• The specific roles of apolipoproteins B (apoB) and E (apoE) in lipoprotein binding and uptake are complex and not fully elucidated.

Purpose of the Study:

• To elucidate the distinct roles of apoB and apoE in the receptor-mediated binding and uptake of various VLDL subclasses and LDL.
• To investigate the mechanism by which hypertriglyceridemic VLDL (HTG-VLDL) interacts with LDL and beta-VLDL receptors.
• To provide insights into the abnormal VLDL metabolism observed in hypertriglyceridemia and its potential link to foam cell formation.

Main Methods:

• Characterization of apoB-mediated binding of small VLDL and IDL to the LDL receptor.
• Assessment of apoE conformation requirements for large VLDL binding to the LDL receptor.
• Evaluation of apoE's role in HTG-VLDL binding to both LDL and beta-VLDL receptors.
• Identification of domains within apoB and apoE essential for beta-VLDL receptor interaction.
• Observational analysis linking lipoprotein catabolism abnormalities to receptor pathways.

Main Results:

• ApoB mediates the binding of small VLDL (Sf 20-60), IDL, and LDL to the LDL receptor.
• Accessible apoE conformation is required for large VLDL binding to the LDL receptor; HTG-VLDL possesses this apoE population, unlike normal VLDL.
• The same apoE population involved in HTG-VLDL binding to the LDL receptor also modulates its binding to the beta-VLDL receptor, though it's not essential for the latter.
• A domain of processed apoB or apoB-48, along with inaccessible apoE, is necessary for beta-VLDL receptor binding and uptake.
• Abnormal VLDL catabolism in hypertriglyceridemia may stem from aberrant HTG-VLDL uptake via LDL or beta-VLDL receptor pathways.

Conclusions:

• ApoB and apoE play differential roles in lipoprotein-receptor interactions, influencing VLDL and LDL metabolism.
• The unique apoE characteristics of HTG-VLDL contribute to its abnormal interaction with key lipoprotein receptors.
• These findings offer a molecular basis for understanding hypertriglyceridemia pathophysiology and suggest a mechanism for macrophage-mediated foam cell formation via apoB/E-lipoprotein processing.